<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36324612</PMID><DateRevised><Year>2022</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1792-1015</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Experimental and therapeutic medicine</Title><ISOAbbreviation>Exp Ther Med</ISOAbbreviation></Journal><ArticleTitle>New&#x2011;onset neuropsychiatric sequelae and 'long&#x2011;COVID' syndrome (Review).</ArticleTitle><Pagination><StartPage>705</StartPage><MedlinePgn>705</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">705</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2022.11641</ELocationID><Abstract><AbstractText>The ongoing coronavirus disease 2019 (COVID-19) pandemic has had a widespread impact on individuals' mental health through indirect psychological and social mechanisms, related to factors such as fear of infection or death, social isolation, lack of social support and financial instability. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has also been associated with the development or recurrence of neuropsychiatric symptoms, both during the acute phase, as well as during the post-acute 'long-COVID' phase. In addition to the COVID-19 survivors with a mental health history that are at a high risk of experiencing a range of neuropsychiatric symptoms following resolution of acute COVID-19, there is accumulating evidence that a diagnosis of COVID-19 may also be associated with new-onset neuropsychiatric morbidity among survivors without pre-existing mental health disorders. In particular, studies investigating the incidence of post-acute neuropsychiatric sequelae, based mostly on retrospective cohort study designs and data from national health registries, have reported the development of new-onset manifestations, including depression, anxiety, psychotic symptoms, sleep disturbances and fatigue. Nevertheless, when COVID-19 survivors were compared with SARS-CoV-2-negative controls and especially survivors of other disorders (such as influenza), the findings regarding the risk of incident neuropsychiatric manifestations varied among studies. While there is evidence of an association between SARS-CoV-2 infection and the subsequent occurrence of new-onset neuropsychiatric symptoms, especially among patients with increased disease severity, further research using methodological approaches less susceptible to confounding bias is required to establish causal relationships.</AbstractText><CopyrightInformation>Copyright: &#xa9; Efstathiou et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Efstathiou</LastName><ForeName>Vasiliki</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefanou</LastName><ForeName>Maria-Ioanna</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demetriou</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siafakas</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Clinical Microbiology Laboratory, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsantoni</LastName><ForeName>Eleni</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Basic Research Center, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makris</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Allergy Unit, Second Department of Dermatology and Venereology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsivgoulis</LastName><ForeName>Georgios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Second Department of Neurology, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zoumpourlis</LastName><ForeName>Vassilios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Biomedical Applications Unit, Institute of Chemical Biology, National Hellenic Research Foundation, 11635 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kympouropoulos</LastName><ForeName>Stylianos P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsoporis</LastName><ForeName>James N</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spandidos</LastName><ForeName>Demetrios A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferentinos</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smyrnis</LastName><ForeName>Nikolaos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizos</LastName><ForeName>Emmanouil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Second Department of Psychiatry, Medical School, National and Kapodistrian University of Athens, 'Attikon' University General Hospital, 12462 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Greece</Country><MedlineTA>Exp Ther Med</MedlineTA><NlmUniqueID>101531947</NlmUniqueID><ISSNLinking>1792-0981</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 survivors</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">incidence of neuropsychiatric symptoms</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">new-onset neuropsychiatric manifestations</Keyword><Keyword MajorTopicYN="N">post-COVID syndrome</Keyword></KeywordList><CoiStatement>DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating the final decision, for this article. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>2</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36324612</ArticleId><ArticleId IdType="pmc">PMC9622976</ArticleId><ArticleId IdType="doi">10.3892/etm.2022.11641</ArticleId><ArticleId IdType="pii">ETM-24-5-11641</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zoumpourlis V, Goulielmaki M, Rizos E, Baliou S, Spandidos DA. [Comment] The COVID-19 pandemic as a scientific and social challenge in the 21st century. Mol Med Rep. 2020;22:3035&#x2013;3048. doi: 10.3892/mmr.2020.11393.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2020.11393</ArticleId><ArticleId IdType="pmc">PMC7453598</ArticleId><ArticleId IdType="pubmed">32945405</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsamakis K, Tsiptsios D, Ouranidis A, Mueller C, Schizas D, Terniotis C, Nikolakakis N, Tyros G, Kympouropoulos S, Lazaris A, et al. COVID-19 and its consequences on mental health (Review) Exp Ther Med. 2021;21(244) doi: 10.3892/etm.2021.9675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.9675</ArticleId><ArticleId IdType="pmc">PMC7851613</ArticleId><ArticleId IdType="pubmed">33603852</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsamakis K, Triantafyllis AS, Tsiptsios D, Spartalis E, Mueller C, Tsamakis C, Chaidou S, Spandidos DA, Fotis L, Economou M, Rizos E. COVID-19 related stress exacerbates common physical and mental pathologies and affects treatment (Review) Exp Ther Med. 2020;20:159&#x2013;162. doi: 10.3892/etm.2020.8671.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.8671</ArticleId><ArticleId IdType="pmc">PMC7271730</ArticleId><ArticleId IdType="pubmed">32509006</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, Stefanou MI, Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Spandidos DA, Smyrnis N, Rizos E. Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review) Exp Ther Med. 2022;23(107) doi: 10.3892/etm.2021.11030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.11030</ArticleId><ArticleId IdType="pmc">PMC8674972</ArticleId><ArticleId IdType="pubmed">34976149</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannopoulou I, Galinaki S, Kollintza E, Adamaki M, Kympouropoulos S, Alevyzakis E, Tsamakis K, Tsangaris I, Spandidos DA, Siafakas N, et al. COVID-19 and post-traumatic stress disorder: The perfect &#x2018;storm&#x2019; for mental health (Review) Exp Ther Med. 2021;22(1162) doi: 10.3892/etm.2021.10596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.10596</ArticleId><ArticleId IdType="pmc">PMC8392877</ArticleId><ArticleId IdType="pubmed">34504607</ArticleId></ArticleIdList></Reference><Reference><Citation> Centers for Disease Control and Prevention (CDC): Post-COVID conditions: Information for healthcare providers, 2021. Available at:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.</Citation></Reference><Reference><Citation>Deer RR, Rock MA, Vasilevsky N, Carmody L, Rando H, Anzalone AJ, Basson MD, Bennett TD, Bergquist T, Boudreau EA, et al. Characterizing long COVID: Deep phenotype of a complex condition. EBioMedicine. 2021;74(103722) doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. 2021;27:28&#x2013;33. doi: 10.1038/s41591-020-01202-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou MI, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E, Grigoriadis N, Krogias C, et al. Neurological manifestations of long-COVID syndrome: A narrative review. Ther Adv Chronic Dis. 2022;13(20406223221076890) doi: 10.1177/20406223221076890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Efstathiou V, Stefanou MI, Demetriou M, Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Kympouropoulos SP, Tsoporis JN, Spandidos DA, et al. Long COVID and neuropsychiatric manifestations (Review) Exp Ther Med. 2022;23(363) doi: 10.3892/etm.2022.11290.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2022.11290</ArticleId><ArticleId IdType="pmc">PMC9019760</ArticleId><ArticleId IdType="pubmed">35493431</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou TM, Joca S, Wegener G, Bay-Richter C. Psychiatric and neuropsychiatric sequelae of COVID-19-A systematic review. Brain Behav Immun. 2021;97:328&#x2013;348. doi: 10.1016/j.bbi.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord. 2022;299:118&#x2013;125. doi: 10.1016/j.jad.2021.11.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8758130</ArticleId><ArticleId IdType="pubmed">34798148</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, et al. Fatigue and cognitive impairment in post-COVID-19 syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2021;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. J Psychiatr Res. 2021;144:129&#x2013;137. doi: 10.1016/j.jpsychires.2021.09.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.09.054</ArticleId><ArticleId IdType="pmc">PMC8482840</ArticleId><ArticleId IdType="pubmed">34619491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S, Tavahomi M, Zanjari N, Ebrahimi-Takamjani I, Amiri-arimi S. Physical and mental health complications post-COVID-19: Scoping review. J Psychosom Res. 2021;147(110525) doi: 10.1016/j.jpsychores.2021.110525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2021.110525</ArticleId><ArticleId IdType="pmc">PMC8133797</ArticleId><ArticleId IdType="pubmed">34051516</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Iosifescu AL, Hoogenboom WS, Buczek AJ, Fleysher R, Duong TQ. New-onset and persistent neurological and psychiatric sequelae of COVID-19 compared to influenza: A retrospective cohort study in a large New York City healthcare network. Int J Methods Psychiatr Res. 2022;31(e1914) doi: 10.1002/mpr.1914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mpr.1914</ArticleId><ArticleId IdType="pmc">PMC9349863</ArticleId><ArticleId IdType="pubmed">35706352</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, Hallas J, Nielsen H, Koch A, Mogensen SH, Brun NC, Christiansen CF, Thomsen RW, Potteg&#xe5;rd A. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: A Danish population-based cohort study. Lancet Infect Dis. 2021;21:1373&#x2013;1382. doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman B, Casiraghi E, Blau H, Chan L, Haendel MA, Laraway B, Callahan TJ, Deer RR, Wilkins KJ, Reese J, Robinson PN. Risk of new-onset psychiatric sequelae of COVID-19 in the early and late post-acute phase. World Psychiatry. 2022;21:319&#x2013;320. doi: 10.1002/wps.20992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20992</ArticleId><ArticleId IdType="pmc">PMC9077621</ArticleId><ArticleId IdType="pubmed">35524622</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel KM, Carr MJ, Ashcroft DM, Chalder T, Chew-Graham CA, Hope H, Kapur N, McManus S, Steeg S, Webb RT, Pierce M. Association of SARS-CoV-2 infection with psychological distress, psychotropic prescribing, fatigue, and sleep problems among UK primary care patients. JAMA Netw Open. 2021;4(e2134803) doi: 10.1001/jamanetworkopen.2021.34803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.34803</ArticleId><ArticleId IdType="pmc">PMC8596199</ArticleId><ArticleId IdType="pubmed">34783824</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N, Dahman B, Bajaj JS. Development of new mental and physical health sequelae among US veterans after COVID-19. J Clin Med. 2022;11(3390) doi: 10.3390/jcm11123390.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11123390</ArticleId><ArticleId IdType="pmc">PMC9225186</ArticleId><ArticleId IdType="pubmed">35743461</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JI, Hickok A, O'Neill AC, Niederhausen M, Laliberte AZ, Govier DJ, Edwards ST, Gordon HS, Slatore CG, Weaver FM, et al. Psychiatric disorders newly diagnosed among veterans subsequent to hospitalization for COVID-19. Psychiatry Res. 2022;312(114570) doi: 10.1016/j.psychres.2022.114570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114570</ArticleId><ArticleId IdType="pmc">PMC9023376</ArticleId><ArticleId IdType="pubmed">35487047</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, Ranger TA, Patone M, Coupland CAC, Hatch R, Thomas K, Hippisley-Cox J, Watkinson P. Neuropsychiatric ramifications of severe COVID-19 and other severe acute respiratory infections. JAMA Psychiatry. 2022;79:690&#x2013;698. doi: 10.1001/jamapsychiatry.2022.1067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1067</ArticleId><ArticleId IdType="pmc">PMC9096686</ArticleId><ArticleId IdType="pubmed">35544272</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: Cohort study. BMJ. 2022;376(e068993) doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HY, Song IA, Lee SH, Sim MY, Oh HS, Song KH, Yu ES, Park HY, Oh TK. Prevalence of mental illness among COVID-19 survivors in South Korea: Nationwide cohort. BJPsych Open. 2021;7(e183) doi: 10.1192/bjo.2021.1001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjo.2021.1001</ArticleId><ArticleId IdType="pmc">PMC8503052</ArticleId><ArticleId IdType="pubmed">34659793</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, L&#xe1;inez-Ramos-Bossini AJ, de Alba IG, Ortiz-Gonz&#xe1;lez-Serna R, Serrano-Ortiz &#xc1;, Fern&#xe1;ndez-Mart&#xed;nez NF, Ruiz-Montero R, Cervilla JA. Long COVID 12 months after discharge: Persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med. 2022;20(92) doi: 10.1186/s12916-022-02292-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02292-6</ArticleId><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob L, Koyanagi A, Smith L, Bohlken J, Haro JM, Kostev K. No significant association between COVID-19 diagnosis and the incidence of depression and anxiety disorder? A retrospective cohort study conducted in Germany. J Psychiatr Res. 2022;147:79&#x2013;84. doi: 10.1016/j.jpsychires.2022.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.01.013</ArticleId><ArticleId IdType="pmc">PMC8741171</ArticleId><ArticleId IdType="pubmed">35026596</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CM, Gilbert EB, Riordan PA, Helmke N, von Isenburg M, Kincaid BR, Shirey KG. COVID-19-associated psychosis: A systematic review of case reports. Gen Hosp Psychiatry. 2021;73:84&#x2013;100. doi: 10.1016/j.genhosppsych.2021.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8546431</ArticleId><ArticleId IdType="pubmed">34717240</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkhamees AA. Obsessive-compulsive disorder post-COVID-19: A case presentation. Egypt J Neurol Psychiatr Neurosurg. 2021;57(150) doi: 10.1186/s41983-021-00405-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41983-021-00405-1</ArticleId><ArticleId IdType="pmc">PMC8557101</ArticleId><ArticleId IdType="pubmed">34744416</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster R, Holroyd S. Prevalence of psychotic symptoms in delirium. Psychosomatics. 2000;41:519&#x2013;522. doi: 10.1176/appi.psy.41.6.519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.41.6.519</ArticleId><ArticleId IdType="pubmed">11110116</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, David AS. A longer look at COVID-19 and neuropsychiatric outcomes. Lancet Psychiatry. 2021;8:351&#x2013;352. doi: 10.1016/S2215-0366(21)00120-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00120-6</ArticleId><ArticleId IdType="pmc">PMC8023693</ArticleId><ArticleId IdType="pubmed">33836149</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CP, Chang CM, Yang CC, Pariante CM, Su KP. Long COVID and long chain fatty acids (LCFAs): Psychoneuroimmunity implication of omega-3 LCFAs in delayed consequences of COVID-19. Brain Behav Immun. 2022;103:19&#x2013;27. doi: 10.1016/j.bbi.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC8977215</ArticleId><ArticleId IdType="pubmed">35390469</ArticleId></ArticleIdList></Reference><Reference><Citation>Druss BG. Addressing the COVID-19 pandemic in populations with serious mental illness. JAMA Psychiatry. 2020;77:891&#x2013;892. doi: 10.1001/jamapsychiatry.2020.0894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2020.0894</ArticleId><ArticleId IdType="pubmed">32242888</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno C, Wykes T, Galderisi S, Nordentoft M, Crossley N, Jones N, Cannon M, Correll CU, Byrne L, Carr S, et al. How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry. 2020;7:813&#x2013;824. doi: 10.1016/S2215-0366(20)30307-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30307-2</ArticleId><ArticleId IdType="pmc">PMC7365642</ArticleId><ArticleId IdType="pubmed">32682460</ArticleId></ArticleIdList></Reference><Reference><Citation>Kola L. Global mental health and COVID-19. Lancet Psychiatry. 2020;7:655&#x2013;657. doi: 10.1016/S2215-0366(20)30235-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30235-2</ArticleId><ArticleId IdType="pmc">PMC7266571</ArticleId><ArticleId IdType="pubmed">32502468</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N. Obsessive-compulsive disorder: Autoimmunity and neuroinflammation. Curr Psychiatry Rep. 2019;21(78) doi: 10.1007/s11920-019-1062-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-019-1062-8</ArticleId><ArticleId IdType="pubmed">31367805</ArticleId></ArticleIdList></Reference><Reference><Citation>Maia TV, Cooney RE, Peterson BS. The neural bases of obsessive-compulsive disorder in children and adults. Dev Psychopathol. 2008;20:1251&#x2013;1283. doi: 10.1017/S0954579408000606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0954579408000606</ArticleId><ArticleId IdType="pmc">PMC3079445</ArticleId><ArticleId IdType="pubmed">18838041</ArticleId></ArticleIdList></Reference><Reference><Citation>Uvais NA. Obsessive-compulsive disorder following COVID-19 infection. Prim Care Companion CNS Disord. 2021;23(21cr03063) doi: 10.4088/PCC.21cr03063.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/PCC.21cr03063</ArticleId><ArticleId IdType="pubmed">34861748</ArticleId></ArticleIdList></Reference><Reference><Citation>Frick L, Pittenger C. Microglial dysregulation in OCD, tourette syndrome and PANDAS. J Immunol Res. 2016;2016(8606057) doi: 10.1155/2016/8606057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8606057</ArticleId><ArticleId IdType="pmc">PMC5174185</ArticleId><ArticleId IdType="pubmed">28053994</ArticleId></ArticleIdList></Reference><Reference><Citation>Awogbindin IO, Ben-Azu B, Olusola BA, Akinluyi ET, Adeniyi PA, Di Paolo T, Tremblay M&#xc8;. Microglial implications in SARS-CoV-2 infection and COVID-19: Lessons from viral RNA neurotropism and possible relevance to Parkinson's disease. Front Cell Neurosci. 2021;15(670298) doi: 10.3389/fncel.2021.670298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.670298</ArticleId><ArticleId IdType="pmc">PMC8240959</ArticleId><ArticleId IdType="pubmed">34211370</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgado P, Freitas D, Bessa JM, Sousa N, Cerqueira JJ. Perceived stress in obsessive-compulsive disorder is related with obsessive but not compulsive symptoms. Front Psychiatry. 2013;4(21) doi: 10.3389/fpsyt.2013.00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2013.00021</ArticleId><ArticleId IdType="pmc">PMC3613755</ArticleId><ArticleId IdType="pubmed">23565098</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Cristillo V, Cotti Piccinelli S, Zoppi N, Bonzi G, Sattin D, Schiavolin S, Raggi A, Canale A, Gipponi S, et al. Long-term neurological manifestations of COVID-19: Prevalence and predictive factors. Neurol Sci. 2021;42:4903&#x2013;4907. doi: 10.1007/s10072-021-05586-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05586-4</ArticleId><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MD. Macrophages: A Trojan horse in COVID-19? Nat Rev Immunol. 2020;20(351) doi: 10.1038/s41577-020-0317-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0317-2</ArticleId><ArticleId IdType="pmc">PMC7186930</ArticleId><ArticleId IdType="pubmed">32303696</ArticleId></ArticleIdList></Reference><Reference><Citation>Tizenberg BN, Brenner LA, Lowry CA, Okusaga OO, Benavides DR, Hoisington AJ, Benros ME, Stiller JW, Kessler RC, Postolache TT. Biological and psychological factors determining neuropsychiatric outcomes in COVID-19. Curr Psychiatry Rep. 2021;23(68) doi: 10.1007/s11920-021-01275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-021-01275-3</ArticleId><ArticleId IdType="pmc">PMC8485771</ArticleId><ArticleId IdType="pubmed">34648081</ArticleId></ArticleIdList></Reference><Reference><Citation>Titze-de-Almeida R, da Cunha TR, dos Santos Silva LD, Ferreira CS, Silva CP, Ribeiro AP, de Castro Moreira Santos J&#xfa;nior A, de Paula Brand&#xe3;o PR, Silva APB, da Rocha MCO, et al. Persistent, new-onset symptoms and mental health complaints in long COVID in a Brazilian cohort of non-hospitalized patients. BMC Infect Dis. 2022;22(133) doi: 10.1186/s12879-022-07065-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07065-3</ArticleId><ArticleId IdType="pmc">PMC8821794</ArticleId><ArticleId IdType="pubmed">35135496</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Mills PJ, Loredo JS, Adler KA, Dimsdale JE. The association between interleukin-6, sleep and demographic characteristics. Brain Behav Immun. 2005;19:165&#x2013;172. doi: 10.1016/j.bbi.2004.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2004.07.008</ArticleId><ArticleId IdType="pubmed">15664789</ArticleId></ArticleIdList></Reference><Reference><Citation>Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16&#x2013;27.e1. doi: 10.1016/j.cell.2020.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.028</ArticleId><ArticleId IdType="pmc">PMC7437501</ArticleId><ArticleId IdType="pubmed">32882182</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson MA, Banks WA. Neuroimmune axes of the blood-brain barriers and blood-brain interfaces: Bases for physiological regulation, disease states and pharmacological interventions. Pharmacol Rev. 2018;70:278&#x2013;314. doi: 10.1124/pr.117.014647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.117.014647</ArticleId><ArticleId IdType="pmc">PMC5833009</ArticleId><ArticleId IdType="pubmed">29496890</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, Damoraki G, Gkavogianni T, Adami ME, Katsaounou P, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27:992&#x2013;1000.e3. doi: 10.1016/j.chom.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon SY, Koo BN. Inflammatory response in COVID-19 patients resulting from the interaction of the inflammasome and SARS-CoV-2. Int J Mol Sci. 2021;22(7914) doi: 10.3390/ijms22157914.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157914</ArticleId><ArticleId IdType="pmc">PMC8348456</ArticleId><ArticleId IdType="pubmed">34360684</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, Hirayama AV, Mastroiani F, Turtle CJ, Harhay MO, et al. Cytokine elevation in severe and critical COVID-19: A rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020;8:1233&#x2013;1244. doi: 10.1016/S2213-2600(20)30404-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30404-5</ArticleId><ArticleId IdType="pmc">PMC7567529</ArticleId><ArticleId IdType="pubmed">33075298</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, Lieberman J. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016;535:153&#x2013;158. doi: 10.1038/nature18629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18629</ArticleId><ArticleId IdType="pmc">PMC5539988</ArticleId><ArticleId IdType="pubmed">27383986</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao N, Di B, Xu LL. The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies. Cytokine Growth Factor Rev. 2021;61:2&#x2013;15. doi: 10.1016/j.cytogfr.2021.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8233448</ArticleId><ArticleId IdType="pubmed">34183243</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah P, Patel J, Soror NN, Kartan R. Encephalopathy in COVID-19 patients. Cureus. 2021;13(e16620) doi: 10.7759/cureus.16620.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.16620</ArticleId><ArticleId IdType="pmc">PMC8384454</ArticleId><ArticleId IdType="pubmed">34458032</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore P, Esmail F, Qin S, Nand S, Berg S. Hypercoagulability of COVID-19 and neurological complications: A review. J Stroke Cerebrovasc Dis. 2022;31(106163) doi: 10.1016/j.jstrokecerebrovasdis.2021.106163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2021.106163</ArticleId><ArticleId IdType="pmc">PMC8547944</ArticleId><ArticleId IdType="pubmed">34763262</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer L, Laksono BM, de Vrij FMS, Kushner SA, Harschnitz O, van Riel D. The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2. Trends Neurosci. 2022;45:358&#x2013;368. doi: 10.1016/j.tins.2022.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2022.02.006</ArticleId><ArticleId IdType="pmc">PMC8890977</ArticleId><ArticleId IdType="pubmed">35279295</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludlow M, Kortekaas J, Herden C, Hoffmann B, Tappe D, Trebst C, Griffin DE, Brindle HE, Solomon T, Brown AS, et al. Neurotropic virus infections as the cause of immediate and delayed neuropathology. Acta Neuropathol. 2016;131:159&#x2013;184. doi: 10.1007/s00401-015-1511-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1511-3</ArticleId><ArticleId IdType="pmc">PMC4713712</ArticleId><ArticleId IdType="pubmed">26659576</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13:379&#x2013;393. doi: 10.1016/j.chom.2013.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2013.03.010</ArticleId><ArticleId IdType="pmc">PMC3647473</ArticleId><ArticleId IdType="pubmed">23601101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fodoulian L, Tuberosa J, Rossier D, Boillat M, Kan C, Pauli V, Egervari K, Lobrinus JA, Landis BN, Carleton A, Rodriguez I. SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain. iScience. 2020;23(101839) doi: 10.1016/j.isci.2020.101839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101839</ArticleId><ArticleId IdType="pmc">PMC7685946</ArticleId><ArticleId IdType="pubmed">33251489</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol. 2022;42:217&#x2013;224. doi: 10.1007/s10571-020-00947-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00947-7</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob F, Pather SR, Huang WK, Zhang F, Wong SZH, Zhou H, Cubitt B, Fan W, Chen CZ, Xu M, et al. Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium. Cell Stem Cell. 2020;27:937&#x2013;950.e9. doi: 10.1016/j.stem.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7505550</ArticleId><ArticleId IdType="pubmed">33010822</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L, Albecka A, Mallery DL, Kellner MJ, Paul D, Carter AP, James LC, Lancaster MA. SARS-CoV-2 infects the brain choroid plexus and disrupts the blood-CSF barrier in human brain organoids. Cell Stem Cell. 2020;27:951&#x2013;961.e5. doi: 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon CL, Staples H, Gazi M, Carrion R, Hsieh J. SARS-CoV-2 targets glial cells in human cortical organoids. Stem Cell Reports. 2021;16:1156&#x2013;1164. doi: 10.1016/j.stemcr.2021.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.01.016</ArticleId><ArticleId IdType="pmc">PMC8111796</ArticleId><ArticleId IdType="pubmed">33979600</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang BZ, Chu H, Han S, Shuai H, Deng J, Hu YF, Gong HR, Lee AC, Zou Z, Yau T, et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30:928&#x2013;931. doi: 10.1038/s41422-020-0390-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0390-x</ArticleId><ArticleId IdType="pmc">PMC7399356</ArticleId><ArticleId IdType="pubmed">32753756</ArticleId></ArticleIdList></Reference><Reference><Citation>Beristain-Covarrubias N, Perez-Toledo M, Thomas MR, Henderson IR, Watson SP, Cunningham AF. Understanding infection-induced thrombosis: Lessons learned from animal models. Front Immunol. 2019;10(2569) doi: 10.3389/fimmu.2019.02569.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02569</ArticleId><ArticleId IdType="pmc">PMC6848062</ArticleId><ArticleId IdType="pubmed">31749809</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, et al. Endotheliopathy in COVID-19-associated coagulopathy: Evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7:e575&#x2013;e582. doi: 10.1016/S2352-3026(20)30216-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlall V, Thangaraj PM, Meydan C, Foox J, Butler D, Kim J, May B, De Freitas JK, Glicksberg BS, Mason CE, et al. Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection. Nat Med. 2020;26:1609&#x2013;1615. doi: 10.1038/s41591-020-1021-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1021-2</ArticleId><ArticleId IdType="pmc">PMC7809634</ArticleId><ArticleId IdType="pubmed">32747830</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, Chinchilli VM. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw Open. 2021;4(e2128568) doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Panariello A, Bassetti R, Radice A, Rossotti R, Puoti M, Corradin M, Moreno M, Percudani M. Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report. Brain Behav Immun. 2020;87:179&#x2013;181. doi: 10.1016/j.bbi.2020.05.054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.054</ArticleId><ArticleId IdType="pmc">PMC7255176</ArticleId><ArticleId IdType="pubmed">32454137</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke C, Ferse C, Kreye J, Reincke SM, Sanchez-Sendin E, Rocco A, Steinbrenner M, Angermair S, Treskatsch S, Zickler D, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415&#x2013;419. doi: 10.1016/j.bbi.2020.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834471</ArticleId><ArticleId IdType="pubmed">33359380</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder J, Feresiadou A, F&#xe4;llmar D, Frithiof R, Virhammar J, Rasmusson A, Rostami E, Kumlien E, Cunningham JL. Autoimmune encephalitis presenting with malignant catatonia in a 40-year-old male patient with COVID-19. Am J Psychiatry. 2021;178:485&#x2013;489. doi: 10.1176/appi.ajp.2020.20081236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2020.20081236</ArticleId><ArticleId IdType="pubmed">34154381</ArticleId></ArticleIdList></Reference><Reference><Citation>Endres D, Maier V, Leypoldt F, Wandinger KP, Lennox B, Pollak TA, Nickel K, Maier S, Feige B, Domschke K, et al. Autoantibody-associated psychiatric syndromes: A systematic literature review resulting in 145 cases. Psychol Med. 2020;52:1&#x2013;12. doi: 10.1017/S0033291720002895. (Epub ahead of print)</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291720002895</ArticleId><ArticleId IdType="pmc">PMC9069350</ArticleId><ArticleId IdType="pubmed">32892761</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson CJ, Thomas RH, Solomon T, Michael BD, Nicholson TR, Pollak TA. COVID-19 and psychosis risk: Real or delusional concern? Neurosci Lett. 2021;741(135491) doi: 10.1016/j.neulet.2020.135491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.135491</ArticleId><ArticleId IdType="pubmed">33220366</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Lavelle M, Boursiquot BC, Wan EY. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, Juno JA, Burrell LM, Kent SJ, Dore GJ, et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzi R, Aghbash PS, Eslami N, Azadi A, Shamekh A, Hemmat N, Entezari-Maleki T, Baghi HB. The role of antigen-presenting cells in the pathogenesis of COVID-19. Pathol Res Pract. 2022;233(153848) doi: 10.1016/j.prp.2022.153848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prp.2022.153848</ArticleId><ArticleId IdType="pmc">PMC8941975</ArticleId><ArticleId IdType="pubmed">35338971</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269. doi: 10.1126/science.abm2052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm2052</ArticleId><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L, et al. COVID-19 and possible links with Parkinson's disease and parkinsonism: From bench to bedside. NPJ Parkinsons Dis. 2020;6(18) doi: 10.1038/s41531-020-00123-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-020-00123-0</ArticleId><ArticleId IdType="pmc">PMC7441399</ArticleId><ArticleId IdType="pubmed">32885037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>